Investors
Segment Data and Regional Results
Quarterly Statement Q3 2024
Segment Data
Q3 segment data — Chemicals
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 2,714 | 2,430 | 11.7% | 8,317 | 7,942 | 4.7% |
of which Petrochemicals |
2,031 | 1,733 | 17.2% | 6,181 | 5,653 | 9.3% |
Intermediates |
683 | 697 | -2.0% | 2,136 | 2,289 | -6.6% |
EBITDA before special items | 342 | 252 | 35.5% | 1,238 | 1,071 | 15.6% |
EBITDA | 342 | 252 | 35.7% | 1,238 | 1,076 | 15.0% |
EBITDA margin before special items (%) | 12.6 | 10.4 | – | 14.9 | 13.5 | – |
Depreciation and amortizationa | 210 | 206 | 2.0% | 623 | 578 | 7.9% |
Income from operations (EBIT) | 132 | 46 | 186.5% | 615 | 499 | 23.3% |
Special items | -2 | -1 | -280.9% | -3 | 9 | . |
EBIT before special items | 134 | 47 | 187.7% | 617 | 490 | 26.0% |
Investments including acquisitionsb | 810 | 616 | 31.6% | 2,278 | 1,672 | 36.2% |
Segment cash flow | -363 | -171 | -112.7% | -1,325 | -327 | -305.7% |
Assets (September 30) | 13,341 | 11,107 | 20.1% | 13,341 | 11,107 | 20.1% |
Research and development expenses | 20 | 19 | 1.9% | 62 | 65 | -4.5% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Materials
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 3,413 | 3,349 | 1.9% | 10,270 | 10,801 | -4.9% |
of which Performance Materials |
1,706 | 1,765 | -3.3% | 5,205 | 5,558 | -6.4% |
Monomers |
1,707 | 1,584 | 7.8% | 5,065 | 5,243 | -3.4% |
EBITDA before special items | 484 | 360 | 34.5% | 1,440 | 1,270 | 13.4% |
EBITDA | 450 | 310 | 45.0% | 1,428 | 1,186 | 20.4% |
EBITDA margin before special items (%) | 14.2 | 10.8 | – | 14.0 | 11.8 | – |
Depreciation and amortizationa | 205 | 203 | 1.0% | 616 | 604 | 1.9% |
Income from operations (EBIT) | 245 | 108 | 127.6% | 812 | 582 | 39.5% |
Special items | -37 | -50 | 25.0% | -22 | -83 | 73.7% |
EBIT before special items | 283 | 158 | 79.4% | 834 | 665 | 25.4% |
Investments including acquisitionsb | 222 | 224 | -0.8% | 734 | 644 | 14.0% |
Segment cash flow | 299 | 354 | -15.6% | 520 | 1,037 | -49.8% |
Assets (September 30) | 10,126 | 10,363 | -2.3% | 10,126 | 10,363 | -2.3% |
Research and development expenses | 43 | 42 | 2.6% | 134 | 136 | -1.3% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Industrial Solutions
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 2,092 | 1,948 | 7.4% | 6,296 | 6,141 | 2.5% |
of which Dispersions & Resins |
1,305 | 1,201 | 8.7% | 3,934 | 3,776 | 4.2% |
Performance Chemicals |
787 | 747 | 5.4% | 2,362 | 2,365 | -0.1% |
EBITDA before special items | 301 | 207 | 45.3% | 953 | 715 | 33.3% |
EBITDA | 293 | 196 | 49.5% | 943 | 766 | 23.2% |
EBITDA margin before special items (%) | 14.4 | 10.6 | – | 15.1 | 11.6 | – |
Depreciation and amortizationa | 86 | 84 | 2.6% | 255 | 261 | -2.2% |
Income from operations (EBIT) | 208 | 113 | 84.3% | 688 | 505 | 36.4% |
Special items | -8 | -10 | 19.1% | -10 | 42 | . |
EBIT before special items | 215 | 122 | 76.1% | 698 | 463 | 50.8% |
Investments including acquisitionsb | 78 | 65 | 19.4% | 182 | 187 | -3.0% |
Segment cash flow | 356 | 416 | -14.4% | 565 | 978 | -42.2% |
Assets (September 30) | 5,753 | 5,798 | -0.8% | 5,753 | 5,798 | -0.8% |
Research and development expenses | 36 | 34 | 6.1% | 107 | 115 | -6.2% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Nutrition & Care
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 1,711 | 1,688 | 1.3% | 5,107 | 5,226 | -2.3% |
of which Care Chemicals |
1,206 | 1,158 | 4.1% | 3,587 | 3,633 | -1.3% |
Nutrition & Health |
505 | 530 | -4.7% | 1,520 | 1,593 | -4.6% |
EBITDA before special items | 201 | 104 | 93.3% | 646 | 435 | 48.5% |
EBITDA | 200 | 95 | 110.6% | 655 | 453 | 44.6% |
EBITDA margin before special items (%) | 11.7 | 6.2 | – | 12.6 | 8.3 | – |
Depreciation and amortizationa | 143 | 119 | 20.2% | 449 | 336 | 33.6% |
Income from operations (EBIT) | 57 | -24 | . | 207 | 117 | 76.2% |
Special items | -1 | -9 | 88.7% | -37 | 18 | . |
EBIT before special items | 58 | -15 | . | 244 | 99 | 145.5% |
Investments including acquisitionsb | 206 | 173 | 19.1% | 533 | 496 | 7.5% |
Segment cash flow | 52 | 157 | -66.6% | 8 | 346 | -97.8% |
Assets (September 30) | 7,675 | 7,702 | -0.4% | 7,675 | 7,702 | -0.4% |
Research and development expenses | 37 | 34 | 9.8% | 111 | 113 | -1.6% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Surface Technologies
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 3,132 | 3,887 | -19.4% | 9,714 | 12,691 | -23.5% |
of which Catalysts |
2,074 | 2,781 | -25.4% | 6,552 | 9,419 | -30.4% |
Coatings |
1,057 | 1,106 | -4.4% | 3,162 | 3,272 | -3.4% |
EBITDA before special items | 341 | 404 | -15.5% | 1,063 | 1,180 | -9.9% |
EBITDA | 306 | 341 | -10.5% | 952 | 1,045 | -8.8% |
EBITDA margin before special items (%) | 10.9 | 10.4 | – | 10.9 | 9.3 | – |
Depreciation and amortizationa | 178 | 148 | 20.3% | 471 | 431 | 9.4% |
Income from operations (EBIT) | 128 | 194 | -33.9% | 481 | 614 | -21.6% |
Special items | -70 | -63 | -11.8% | -146 | -137 | -6.5% |
EBIT before special items | 199 | 257 | -22.7% | 627 | 750 | -16.5% |
Investments including acquisitionsb | 127 | 131 | -2.9% | 330 | 363 | -9.2% |
Segment cash flow | 232 | 307 | -24.4% | 714 | 1,041 | -31.4% |
Assets (September 30) | 12,104 | 13,479 | -10.2% | 12,104 | 13,479 | -10.2% |
Research and development expenses | 77 | 67 | 15.5% | 241 | 226 | 7.0% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Agricultural Solutions
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 1,849 | 1,744 | 6.0% | 7,264 | 7,865 | -7.6% |
EBITDA before special items | 49 | 225 | -78.4% | 1,544 | 2,049 | -24.6% |
EBITDA | -190 | 213 | . | 1,291 | 2,034 | -36.5% |
EBITDA margin before special items (%) | 2.6 | 12.9 | – | 21.3 | 26.1 | – |
Depreciation and amortizationa | 170 | 172 | -1.1% | 504 | 524 | -3.8% |
Income from operations (EBIT) | -360 | 41 | . | 788 | 1,511 | -47.9% |
Special items | -239 | -12 | . | -256 | -15 | . |
EBIT before special items | -121 | 53 | . | 1,044 | 1,526 | -31.6% |
Investments including acquisitionsb | 82 | 72 | 13.3% | 201 | 234 | -14.2% |
Segment cash flow | 612 | 853 | -28.2% | 902 | 1,174 | -23.1% |
Assets (September 30) | 15,748 | 17,427 | -9.6% | 15,748 | 17,427 | -9.6% |
Research and development expenses | 226 | 208 | 8.6% | 677 | 655 | 3.4% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
Q3 segment data — Other
Q3 | January–September | |||||
Million € | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Sales to third parties | 829 | 689 | 20.2% | 2,436 | 2,365 | 3.0% |
EBITDA before special items | -96 | -8 | . | -594 | -367 | -62.0% |
of which costs for cross-divisional corporate research |
-56 | -64 | 12.1% | -159 | -189 | 16.1% |
costs of corporate headquarters |
-55 | -54 | -2.0% | -173 | -173 | 0.3% |
other businesses |
41 | 29 | 38.7% | 111 | 89 | 25.4% |
foreign currency results, hedging and other measurement effects |
-26 | -3 | -668.5% | -65 | -29 | -124.8% |
miscellaneous income and expenses |
0 | 84 | -100.0% | -309 | -64 | -383.4% |
EBITDA | -124 | -45 | -173.7% | -1,014 | -479 | -111.5% |
Depreciation and amortizationa | 36 | 38 | -6.7% | 121 | 113 | 7.0% |
Income from operations (EBIT) | -159 | -83 | -91.2% | -1,135 | -592 | -91.6% |
Special items | -27 | -37 | 29.2% | -429 | -113 | -281.2% |
EBIT before special items | -133 | -46 | -189.3% | -705 | -480 | -47.1% |
Investments including acquisitionsb | 43 | 35 | 22.4% | 153 | 106 | 43.4% |
Assets (September 30)c | 14,611 | 16,726 | -12.6% | 14,611 | 16,726 | -12.6% |
Research and development expenses | 66 | 76 | -12.9% | 187 | 225 | -17.1% |
a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments)
b Additions to property, plant and equipment and intangible assets
c Includes assets of businesses recognized under Other and reconciliation to assets of the BASF Group
Regions
Million € | Sales by location of company |
Sales by location of customer |
||||
Q3 | 2024 | 2023 | +/- | 2024 | 2023 | +/- |
Europe | 6,211 | 5,941 | 4.6% | 5,842 | 5,740 | 1.8% |
of which Germany |
2,717 | 2,547 | 6.7% | 1,562 | 1,564 | -0.1% |
North America | 3,945 | 3,939 | 0.2% | 3,863 | 3,752 | 3.0% |
Asia Pacific | 4,033 | 4,250 | -5.1% | 4,102 | 4,290 | -4.4% |
of which Greater China |
2,162 | 2,415 | -10.5% | 2,151 | 2,397 | -10.2% |
South America, Africa, Middle East | 1,550 | 1,604 | -3.4% | 1,932 | 1,953 | -1.0% |
BASF Group | 15,739 | 15,735 | 0.0% | 15,739 | 15,735 | 0.0% |
January – September | ||||||
Europe | 20,318 | 21,532 | -5.6% | 19,303 | 20,507 | -5.9% |
of which Germany |
8,495 | 8,810 | -3.6% | 4,798 | 5,305 | -9.6% |
North America | 13,686 | 14,777 | -7.4% | 13,386 | 14,563 | -8.1% |
Asia Pacific | 11,928 | 13,056 | -8.6% | 12,208 | 13,231 | -7.7% |
of which Greater China |
6,540 | 7,128 | -8.2% | 6,490 | 7,059 | -8.1% |
South America, Africa, Middle East | 3,471 | 3,666 | -5.3% | 4,506 | 4,730 | -4.7% |
BASF Group | 49,403 | 53,031 | -6.8% | 49,403 | 53,031 | -6.8% |